Herpes Zoster ophthalmicus after Covid-19 vaccination: A new perspective for health professionals
DOI:
https://doi.org/10.33448/rsd-v13i11.47263Keywords:
Herpes Zoster Ophthalmicus; Health professionals; SARS-CoV-2; Vaccination.Abstract
Herpes Zoster is a disease marked by the Varicella-Zoster Virus (VZV) reactivation. The ophthalmic branch of the trigeminal nerve can be affected by the pathogen, causing Herpes Zoster Ophthalmicus (HZO). In this context, the virus reactivation in the ophthalmic branch of the trigeminal nerve was frequently described in the literature as possibly associated with vaccination against SARS-CoV-2. Such occurrences were scarce, but statistically significant. The studies also pointed out a unique pattern in the proportion of people affected by HZ according to the nature of the vaccine, so that those using mRNA as an antigen were the most frequent. Thus, this study aimed to report the case of a 23-year-old Brazilian woman, immunocompetent, who developed HZO about a month and a half after taking the second dose of CoronaVac®, an inactivated virus vaccine, and complained of pain in the form of stabbing and burning in the supraorbital and orbital regions of the left hemiface, culminating in the formation of painful and reddish vesicular lesions. It is concluded that there is evidence linking vaccination and the reported reactivation. Therefore, it is important to disseminate these data among health professionals in order to ensure the safety of vaccination of individuals who are part of the risk group, without discouraging their immunization.
References
Amblard, M. A., Costantini, E., Hayek, G., & Ricaud, X. (2022). Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients. Journal Francais D'ophtalmologie, 45(9), 1000-1003.
Antoniolli, L., Rodrigues, C., Borges, R., & Goldani, L. Z. (2019). Epidemiology and clinical characteristics of herpes zoster in a tertiary care hospital in Brazil. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases, 23(2), 143–145. https://doi.org/10.1016/j.bjid.2019.03.001.
Arruda, J. A. A., Radnai, J. L. P. B., Silva, L. V. O., Souza Neta, I. F., Figueiredo, E. L., Alvares, P. R., & Silveira, M. M. F. (2016). Zóster com comprometimento do nervo trigêmeo: Relato de Caso. Revista de Cirurgia e Traumatologia Buco-Maxilo-Facial, 16-4, 45-48. Recuperado de: http://revodonto.bvsalud.org/scielo.php?script=sci_arttext&pid=S1808-52102016000400009.
Bandeira, F., Roizenblatt, M., Levi, G. C., Freitas, D., & Belfort J, R. (2016). Herpes zoster ophthalmicus and varicella zoster virus vasculopathy. Arquivos Brasileiros de Oftalmologia, São Paulo, 79 (2), 126-129. https://doi.org/10.5935/0004-2749.20160038.
Bardach, A. E., Palermo, C., Alconada, T., Sandoval, M., Balan, D. J., Nieto Guevara, J, Gómez, J., & Ciapponi, A. (2021). Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis. PLoS ONE, 16 (2), e0255877. https://doi.org/10.1371/journal.pone.0255877.
Campos, S. M., Alcañiz, M. T. T., Mora, V. I., Almiñana, A. J. A., & Romero, C. M. A. (2022). Herpes Zoster Ophthalmicus presenting as acute headache. Andes Pediatrica: Revista Chilena de Pediatria, 93(2), 270-275. https://doi.org/10.32641/andespediatr.v93i2.3678
Cohen, E. J., & Jeng, B. H. (2021). Herpes zoster: A brief definitive review. Cornea, 40 (8), 943-949. https://doi.org/10.1097/ICO.0000000000002754.
Dam, C., Lede, I., Schaar, J., Al-Dulaimy, M., Rösken, R., & Smits, M. (2021). Herpes zoster after COVID vaccination. International Journal of Infectious Diseases, 111, 169-171. https://doi.org/10.1016/j.ijid.2021.08.048
Desai, H. D., Sharma, K., Shah, A., Patoliya, J., Patil, A., Hooshanginezhad, Z., Grabbe, S., & Goldust, M. (2021). Can SARS‐CoV‐2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review. Journal of Cosmetic Dermatology, 20 (11), 3350-3361. http://dx.doi.org/10.1111/jocd.14521.
Diehl, R., Wiedenmann, C., Reinhard, T., Böhringer, D., & Schauer, F. (2023). Increasing hospitalisation of patients with herpes zoster ophthalmicus—an interdisciplinary retrospective analysis. Graefe's Archive for Clinical and Experimental Ophthalmology, 262 (2), 583-588. https://doi.org/10.1007/s00417-023-06277-w.
Hokazono, K., Oliveira, M., Moura, F. C., & Monteiro, M. L. R. (2009). Síndrome do ápice orbitário causada por herpes zóster oftálmico: relato de caso e revisão da literatura. Revista Brasileira de Oftalmologia, 68, 304-308. https://doi.org/10.1590/S0034-72802009000500009
Kluger, N., Klimenko, T., & Bosonnet, S. (2021). Herpes simplex, herpes zoster, and periorbital erythema flare-ups after SARS-CoV-2 vaccination: 4 cases. Annales de Dermatologie et de Vénéréologie, 149 (3), 45-48. https://doi.org/10.1016/j.annder.2021.07.009.
Lazzaro, D. R., Ramachandran, R., Cohen, E., & Galetta, S. L. (2022). Covid-19 vaccination and possible link to Herpes zoster. American journal of ophthalmology case reports, 25, 101359. https://doi.org/10.1016/j.ajoc.2022.101359.
Ma, J., Wan, Y., Yang, L., Huang, D., & Zhou, H. (2023). Dual-neuromodulation strategy in pain management of herpes zoster ophthalmicus: retrospective cohort study and literature review. Annals of medicine, 55(2), 2288826. https://doi.org/10.1080/07853890.2023.2288826
Martínez-Reviejo, R., Tejada, S., Adebanjo, G. Ar., Chelo, C., Machado, M. C., Parisella, F. R., Campins, M., Tammaro, A., & Rello, J. (2022). Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights. European Journal of Internal Medicine, 104, 73-79. https://doi.org/10.1016/j.ejim.2022.07.022.
Minor, M., & Payne, E. (2023). Herpes zoster ophthalmicus. In: StatPearls [Internet]. StatPearls Publishing.
Moore, K. L., Dalley, A. F., Agur, A. M. R. (2014). Anatomia Orientada para a Clínica. Rio de Janeiro (7a ed.), RJ: Guanabara Koogan.
Morera, A. E., Reyes, E. R., & Herrera, T. M. (2010). Enfoque multidisciplinario en el tratamiento del herpes zóster oftálmico. Revista Cubana de Medicina General Integral, 26(4), 727-731.
Pala, E., Bayraktar, M., & Calp, R. (2024). The potential association between herpes zoster and COVID-19 vaccination. Heliyon, 10, e25738. https://doi.org/10.1016/j.heliyon.2024.e25738.
Patil, A., Goldust, M., & Wollina, U. (2022). Herpes zoster: a review of clinical manifestations and management. Viruses, 14(2), 192. https://doi.org/10.3390/v14020192.
Pelloni, L. S., Pelloni, R., & Borradori, L. (2020). Herpes zoster of the trigeminal nerve with multi-dermatomal involvement: a case report of an unusual presentation. BMC dermatology, 20(1), 12. https://doi.org/10.1186/s12895-020-00110-1.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. (1. ed.). Santa Maria: UFSM.
Plasencia, M., & McQueen, B. R. (2023). Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus: A Case of Irreversible Optic Nerve Damage. Cureus, 15(10). https://doi.org/10.7759%2Fcureus.46522.
Shahrudin, M. S., Mohamed-Yassin, M., & Nik, N. M. (2023). Herpes zoster following COVID-19 vaccine. American Journal of Case Reports, 24, e938667. https://doi.org/10.12659/AJCR.938667.
Snyder, A., Mousa, H., Soifer, M., Jammal, A., Aggarwal, S., & Perez, V. L. (2023). Increasing rates of herpes zoster ophthalmicus and the COVID-19 pandemic. Research Square, 1, e2891711. https://doi.org/10.21203/rs.3.rs-2891711/v1.
Takai, Y. Sr, Yamagami, A., Iwasa, M., Inoue, K., & Wakakura, M. (2023). A case of herpes zoster ophthalmicus with multiple delayed ocular complications. Cureus,15(4). https://doi.org/10.7759%2Fcureus.37134.
Tsatsos, M., Athanasiadis, I., Myrou, A., Saleh, G. M., & Ziakas, N. (2022). Herpes zoster ophthalmicus: a devastating disease coming back with vengeance or finding its nemesis?. Journal of Ophthalmic & Vision Research, 17(1), 123. https://doi.org/10.18502%2Fjovr.v17i1.10177.
Varoğlu, A. O., & Avarisli, A. (2021). Advanced Age and Multiple Comorbidities as Important Factors in Predicting Poor Prognosis in Herpes Zoster Ophthalmicus. Cureus, 13 (9). https://doi.org/10.7759%2Fcureus.18412.
Wan, E. Y. F., Chui, C. S. L., Wang, Y., Ng, V. W. S., Yan, V. K. C., Lai, F. T. T., LI, X., Wong, C. K. H., Chan, E. W. Y., Wonhg, C. S. M., Leyng, K. S. M., Ni, M. Y., Valkenbug, S. A., Peiris, J. S. M., Wu, K. T. J., Cowling, B. J., Ashcroft, D. M., Hung, I. F. N., Leung, G. M., & Wong, I. C. K.. (2022). Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. The Lancet Regional Health–Western Pacific, 21. https://doi.org/10.1016/j.lanwpc.2022.100393.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Amanda Dantas Barbosa; Leonardo Trajano de Oliveira Vieria ; Paulo Eduardo de Lima Lourenço; Rayanne do Nascimento Rodrigues; Ana Karine Farias da Trindade Coelho Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
